{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:04:53Z","timestamp":1779930293533,"version":"3.53.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,17]]},"DOI":"10.7759\/cureus.80727","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T20:03:31Z","timestamp":1742241811000},"source":"Crossref","is-referenced-by-count":2,"title":["Prostate Cancer With Orbital Metastasis"],"prefix":"10.7759","author":[{"given":"Swathi","family":"Gopishetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Aqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Elhalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ezekwudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla P","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019, 10:63-89.","journal-title":"World J Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14041004","article-title":"Clinical management of prostate cancer in high-risk genetic mutation carriers","volume":"14","author":"Clark R","year":"2022","unstructured":"Clark R, Herrera-Caceres J, Kenk M, Fleshner N. Clinical management of prostate cancer in high-risk genetic mutation carriers. Cancers (Basel). 2022, 14:10.3390\/cancers14041004","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller KD","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, et al.. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022, 72:409-36. 10.3322\/caac.21731","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha M","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022, 27:10.3390\/molecules27175730","journal-title":"Molecules"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073753","article-title":"Hereditary prostate cancer: genes related, target therapy and prevention","volume":"22","author":"Vietri MT","year":"2021","unstructured":"Vietri MT, D'Elia G, Caliendo G, et al.. Hereditary prostate cancer: genes related, target therapy and prevention. Int J Mol Sci. 2021, 22:10.3390\/ijms22073753","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22742","article-title":"Distribution of metastatic sites in patients with prostate cancer: a population-based analysis","volume":"74","author":"Gandaglia G","year":"2014","unstructured":"Gandaglia G, Abdollah F, Schiffmann J, et al.. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014, 74:210-6. 10.1002\/pros.22742","journal-title":"Prostate"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf L","year":"2000","unstructured":"Bubendorf L, Sch\u00f6pfer A, Wagner U, et al.. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000, 31:578-83. 10.1053\/hp.2000.6698","journal-title":"Hum Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(97)30148-1","article-title":"Survey of 520 eyes with uveal metastases","volume":"104","author":"Shields CL","year":"1997","unstructured":"Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997, 104:1265-76. 10.1016\/s0161-6420(97)30148-1","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010094","article-title":"Orbital metastases: a systematic review of clinical characteristics, management strategies, and treatment outcomes","volume":"14","author":"Palmisciano P","year":"2021","unstructured":"Palmisciano P, Ferini G, Ogasawara C, et al.. Orbital metastases: a systematic review of clinical characteristics, management strategies, and treatment outcomes. Cancers (Basel). 2021, 14:10.3390\/cancers14010094","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0433","article-title":"Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial","volume":"18","author":"Smith MR","year":"2022","unstructured":"Smith MR, Hussain M, Saad F, et al.. Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial. Future Oncol. 2022, 18:2585-97. 10.2217\/fon-2022-0433","journal-title":"Future Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033688","article-title":"Metastases in prostate cancer","volume":"9","author":"Manna F","year":"2019","unstructured":"Manna F, Karkampouna S, Zoni E, De Menna M, Hensel J, Thalmann GN, Kruithof-de Julio M. Metastases in prostate cancer. Cold Spring Harb Perspect Med. 2019, 9:10.1101\/cshperspect.a033688","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20943","article-title":"A case report on atypical presentation of metastatic prostate cancer","volume":"14","author":"Lyonga Ngonge A","year":"2022","unstructured":"Lyonga Ngonge A, Amadife SN, Wireko FW, Ikwu I, Poddar V. A case report on atypical presentation of metastatic prostate cancer. Cureus. 2022, 14:e20943. 10.7759\/cureus.20943","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.627379","article-title":"Metastatic spread in prostate cancer patients influencing radiotherapy response","volume":"10","author":"Klusa D","year":"2020","unstructured":"Klusa D, Lohaus F, Furesi G, et al.. Metastatic spread in prostate cancer patients influencing radiotherapy response. Front Oncol. 2020, 10:627379. 10.3389\/fonc.2020.627379","journal-title":"Front Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/meajo.MEAJO_93_18","article-title":"Orbital metastases: when to suspect? when to biopsy?","volume":"25","author":"Allen RC","year":"2018","unstructured":"Allen RC. Orbital metastases: when to suspect? when to biopsy?. Middle East Afr J Ophthalmol. 2018, 25:60-4. 10.4103\/meajo.MEAJO_93_18","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2019.07.24","article-title":"Rare sites of breast cancer metastasis: a review","volume":"8","author":"Di Micco R","year":"2019","unstructured":"Di Micco R, Santurro L, Gasparri ML, et al.. Rare sites of breast cancer metastasis: a review. Transl Cancer Res. 2019, 8:S518-52. 10.21037\/tcr.2019.07.24","journal-title":"Transl Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.72.862.10673942","article-title":"Features of unusual metastases from prostate cancer","volume":"72","author":"Long MA","year":"1999","unstructured":"Long MA, Husband JE. Features of unusual metastases from prostate cancer. Br J Radiol. 1999, 72:933-41. 10.1259\/bjr.72.862.10673942","journal-title":"Br J Radiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1722635","article-title":"Primary malignant orbital tumors","volume":"82","author":"Laplant J","year":"2021","unstructured":"Laplant J, Cockerham K. Primary malignant orbital tumors. J Neurol Surg B Skull Base. 2021, 82:81-90. 10.1055\/s-0040-1722635","journal-title":"J Neurol Surg B Skull Base"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21498","article-title":"Survey of orbital tumors at a comprehensive cancer center in the United States","volume":"33","author":"Shinder R","year":"2011","unstructured":"Shinder R, Al-Zubidi N, Esmaeli B. Survey of orbital tumors at a comprehensive cancer center in the United States. Head Neck. 2011, 33:610-4. 10.1002\/hed.21498","journal-title":"Head Neck"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00002341-200109000-00009","article-title":"Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture","volume":"17","author":"Shields JA","year":"2001","unstructured":"Shields JA, Shields CL, Brotman HK, Carvalho C, Perez N, Eagle Jr RC. Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture. Ophthalmic Plast Reconstr Surg. 2001, 17:346-54. 10.1097\/00002341-200109000-00009","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"ref20","article-title":"Cancer metastatic to the orbit: The 2012 Zimmerman lecture","author":"Shields JA","year":"2012","unstructured":"Shields JA, Shields CL, Brotman HK, Carvalho C, Perez N, Eagle Jr RC. Cancer metastatic to the orbit: The 2012 Zimmerman lecture. Ophthalmic Plast Reconstr Surg. 2012,","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26525","article-title":"Multimodal treatments for advanced prostate cancer","volume":"10","author":"Faiena I","year":"2019","unstructured":"Faiena I, Kim IY, Jang TL. Multimodal treatments for advanced prostate cancer. Oncotarget. 2019, 10:255-6. 10.18632\/oncotarget.26525","journal-title":"Oncotarget"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2021.07.010","article-title":"High-risk locally advanced prostate cancer: multimodal treatment is the key","volume":"38","author":"Terlizzi M","year":"2022","unstructured":"Terlizzi M, Bossi A. High-risk locally advanced prostate cancer: multimodal treatment is the key. Eur Urol Open Sci. 2022, 38:14-6. 10.1016\/j.euros.2021.07.010","journal-title":"Eur Urol Open Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/318441-prostate-cancer-with-orbital-metastasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T20:03:33Z","timestamp":1742241813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/318441-prostate-cancer-with-orbital-metastasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.80727","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,17]]}}}